Chemomab Therapeutics Ltd.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $3.0M | $12.8M | $7.5M |
| FY2019 | $4.8M | $19.8M | $17.6M |
| FY2020 | $1.7M | $12.5M | $11.7M |
| FY2021 | $2.9M | $64.4M | $15.2M |
| FY2022 | $6.8M | $43.1M | $13.5M |
| FY2023 | $5.2M | $22.2M | $9.3M |
| FY2024 | $3.4M | $17.0M | $6.1M |
| FY2025 | $1.5M | $13.8M | $7.6M |